BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33782531)

  • 1. mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies.
    Rustad EH; Nadeu F; Angelopoulos N; Ziccheddu B; Bolli N; Puente XS; Campo E; Landgren O; Maura F
    Commun Biol; 2021 Mar; 4(1):424. PubMed ID: 33782531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mutational Signature Comprehensive Analysis Toolkit (musicatk) for the Discovery, Prediction, and Exploration of Mutational Signatures.
    Chevalier A; Yang S; Khurshid Z; Sahelijo N; Tong T; Huggins JH; Yajima M; Campbell JD
    Cancer Res; 2021 Dec; 81(23):5813-5817. PubMed ID: 34625425
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Yang Z; Pandey P; Marjoram P; Siegmund KD
    F1000Res; 2020; 9():586. PubMed ID: 33299548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
    Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
    Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational Signatures in Cancer: Laboratory Considerations and Emerging Applications.
    Dong F; Davies KD
    J Mol Diagn; 2023 Nov; 25(11):790-795. PubMed ID: 37633594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. signeR: an empirical Bayesian approach to mutational signature discovery.
    Rosales RA; Drummond RD; Valieris R; Dias-Neto E; da Silva IT
    Bioinformatics; 2017 Jan; 33(1):8-16. PubMed ID: 27591080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mutational signatures with yet another package for signature analysis.
    Hübschmann D; Jopp-Saile L; Andresen C; Krämer S; Gu Z; Heilig CE; Kreutzfeldt S; Teleanu V; Fröhling S; Eils R; Schlesner M
    Genes Chromosomes Cancer; 2021 May; 60(5):314-331. PubMed ID: 33222322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
    Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
    Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.
    Shumilov E; Flach J; Pabst T; Fiedler M; Angelillo-Scherrer A; Trümper L; Joncourt R; Kohlmann A; Bacher U
    Crit Rev Oncol Hematol; 2018 Jun; 126():64-79. PubMed ID: 29759569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMuS: simultaneous fitting and de novo imputation of cancer mutational signature.
    Cartolano M; Abedpour N; Achter V; Yang TP; Ackermann S; Fischer M; Peifer M
    Sci Rep; 2020 Nov; 10(1):19316. PubMed ID: 33168834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signatures of mutational processes in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
    Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework for mutational signature analysis based on DNA shape parameters.
    Karolak A; Levatić J; Supek F
    PLoS One; 2022; 17(1):e0262495. PubMed ID: 35015788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
    Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
    Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
    Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance.
    Omichessan H; Severi G; Perduca V
    PLoS One; 2019; 14(9):e0221235. PubMed ID: 31513583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer.
    Wojtowicz D; Sason I; Huang X; Kim YA; Leiserson MDM; Przytycka TM; Sharan R
    Genome Med; 2019 Jul; 11(1):49. PubMed ID: 31349863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.
    Shiraishi Y; Tremmel G; Miyano S; Stephens M
    PLoS Genet; 2015 Dec; 11(12):e1005657. PubMed ID: 26630308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. decompTumor2Sig: identification of mutational signatures active in individual tumors.
    Krüger S; Piro RM
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):152. PubMed ID: 30999866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ScalpelSig Designs Targeted Genomic Panels from Data to Detect Activity of Mutational Signatures.
    Franzese N; Fan J; Sharan R; Leiserson MDM
    J Comput Biol; 2022 Jan; 29(1):56-73. PubMed ID: 34986026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of mutational signature software on correlated signatures.
    Wu Y; Chua EHZ; Ng AWT; Boot A; Rozen SG
    Sci Rep; 2022 Jan; 12(1):390. PubMed ID: 35013428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.